Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06949280 · ClinicalTrials.gov registry record · NA

Metabolic Health, Bones and Nuts During Weight Loss in Adults

A NA study of Weight Loss and Obesity and Overweight, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT06949280: Recruiting NA study of Weight Loss and Obesity and Overweight, sponsored by Rutgers, The State University of New Jersey.

NCT06949280 is a NA study of Weight Loss and Obesity and Overweight that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 44 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06949280, a NA study of Weight Loss and Obesity and Overweight, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The aging population is rapidly increasing, and it is important to identify dietary factors that can prevent disease and promote health in this group. Legumes, such as peanuts, are a plant-based food high in protein and unsaturated fat making this a healthy choice but are not consumed frequently enough in older adults. Studies have shown that regular nut consumption is associated with lower adiposity and reduced weight gain, and several dietary pattern studies indicate that nuts and legumes are associated with better bone health. In addition, our preliminary translational data indicates that a higher monounsaturated fatty acid (MUFA) intake is associated with improved bone mineral density (BMD) and quality. Given these findings, the proposed study aims to examine the impact of consuming peanut products on bone health, metabolic health (e.g., serum glucose, insulin, lipids and inflammation), markers of brain and sleep health, and physical function in overweight and obese older adults before and after a six-month weight loss intervention using a randomized controlled design. The results of this study have the potential to provide valuable insights into the role of peanuts as a sources of fatty acids in promoting health and preventing disease in at-risk adults.

Primary Outcome

dual energy x-ray absorptiometry; g/cm2

Interventions

  • DIETARY_SUPPLEMENT Peanut Snack Experimental
  • DIETARY_SUPPLEMENT Nut-free Snack

Study Locations (1)

New Jersey

  • Rutgers University - NJ Inst Food Nutrition & Health - New Brunswick

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2025-05-01
Est. Completion 2027-12-31
Phase NA

What NCT06949280 shows while recruiting

NCT06949280 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Peanut Snack Experimental is the first listed.

NCT06949280 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06949280 about?

NCT06949280 is a clinical study titled "Metabolic Health, Bones and Nuts During Weight Loss in Adults". The aging population is rapidly increasing, and it is important to identify dietary factors that can prevent disease and promote health in this group. Legumes, such as peanuts, are a plant-based food high in protein and unsaturated fat making this a healthy choice but are not consumed frequently eno...

What is the current status of trial NCT06949280?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2025-05-01. Estimated completion is 2027-12-31.

What conditions does trial NCT06949280 study?

This clinical trial studies the following conditions: Weight Loss, Obesity and Overweight, Bone Density.

What interventions are being tested in trial NCT06949280?

The interventions under investigation include: Peanut Snack Experimental (DIETARY_SUPPLEMENT), Nut-free Snack (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06949280?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06949280 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06949280's enrollment target sits among peer trials

44 83rd of 116 higher than 34 of 116 other Weight Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06949280, the US trial registry maintained by the National Library of Medicine. NCT06949280 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.